Rohan Kulkarni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rohan Kulkarni has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Charles Keith Ozaki
Department of Surgery and the Heart and Vascular Center, Brigham & Women’s Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
1 shared publication - Irene B. Helenowski
Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, USA
1 shared publication - Joel L. Ramirez
Division of Vascular & Endovascular Surgery, University of California San Francisco, San Francisco, CA 94143, USA
1 shared publication - Karen J. Ho
Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
1 shared publication - Katharine G. Harris
Department of Medicine, University of Chicago, Chicago, IL, USA
1 shared publication - Liqun Xiong
Division of Vascular Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
1 shared publication
Latest Publications
- 29 May 2024
- Published by Springer Nature
- p. 209-218
Current Management of Post-operative Mesenteric Ischemia
- 29 May 2024
- Published by Springer Nature
- p. 209-218
Current Management of Post-operative Mesenteric Ischemia
- Open Access
- 19 October 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (10) , 2065
Plasma Gut Microbe-Derived Metabolites Associated with Peripheral Artery Disease and Major Adverse Cardiac Events
Cardiovascular diseases are associated with gut dysbiosis, but the role of microbe-derived metabolites as biomarkers or modulators of cardiovascular disease are not well understood. This is a targeted metabolomics study to investigate the association of nine microbe-derived metabolites with lower extremity peripheral artery disease (PAD), a form of atherosclerosis, and major adverse cardiac events (MACE). The study cohort consists of individuals with intermittent claudication and ankle-brachial index (ABI) < 0.9 (N = 119) and controls without clinically-apparent atherosclerosis (N = 37). The primary endpoint was MACE, a composite endpoint of myocardial infarction, coronary revascularization, stroke, transient ischemic attack, or cardiac-related death. Plasma metabolite concentrations differed significantly between the PAD and control groups. After adjustment for traditional atherosclerosis risk factors, kynurenine, hippuric acid, indole-3-propionic acid (IPA), and indole-3-aldehyde (I3A) concentrations were negatively associated with PAD, whereas indoxyl sulfate and 3-hydroxyanthranilic acid were positively associated. Hippuric acid, IPA, and I3A correlated with ABI, a surrogate for atherosclerotic disease burden. Those in the highest I3A concentration quartile had significantly improved freedom from MACE during follow-up compared to those in the lowest quartile. This study identifies specific indole- and phenyl-derived species impacted by gut microbial metabolic pathways that could represent novel microbiome-related biomarkers of PAD.
- 19 October 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (10) , 2065
Open AccessPlasma Gut Microbe-Derived Metabolites Associated with Peripheral Artery Disease and Major Adverse Cardiac Events
Cardiovascular diseases are associated with gut dysbiosis, but the role of microbe-derived metabolites as biomarkers or modulators of cardiovascular disease are not well understood. This is a targeted metabolomics study to investigate the association of nine microbe-derived metabolites with lower extremity peripheral artery disease (PAD), a form of atherosclerosis, and major adverse cardiac events (MACE). The study cohort consists of individuals with intermittent claudication and ankle-brachial index (ABI) < 0.9 (N = 119) and controls without clinically-apparent atherosclerosis (N = 37). The primary endpoint was MACE, a composite endpoint of myocardial infarction, coronary revascularization, stroke, transient ischemic attack, or cardiac-related death. Plasma metabolite concentrations differed significantly between the PAD and control groups. After adjustment for traditional atherosclerosis risk factors, kynurenine, hippuric acid, indole-3-propionic acid (IPA), and indole-3-aldehyde (I3A) concentrations were negatively associated with PAD, whereas indoxyl sulfate and 3-hydroxyanthranilic acid were positively associated. Hippuric acid, IPA, and I3A correlated with ABI, a surrogate for atherosclerotic disease burden. Those in the highest I3A concentration quartile had significantly improved freedom from MACE during follow-up compared to those in the lowest quartile. This study identifies specific indole- and phenyl-derived species impacted by gut microbial metabolic pathways that could represent novel microbiome-related biomarkers of PAD.
- 22 October 2021
- Published by Springer Nature
- p. 213-230
Use of Kalman Filter and Its Variants in State Estimation: A Review
- 22 October 2021
- Published by Springer Nature
- p. 213-230
Use of Kalman Filter and Its Variants in State Estimation: A Review